Prostate Cancer - Results from #21140

Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: Our experience in 242 cases - Abstract March 1, 2014

Randomized phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer - Abstract March 1, 2014

Optimization of tomotherapy treatment planning for patients with bilateral hip prostheses - Abstract March 1, 2014

Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer - Abstract February 28, 2014

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study - Abstract February 28, 2014

Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: Comparison of PSA slope and nadir - Abstract February 27, 2014

Molecular imaging of urogenital diseases - Abstract February 27, 2014

Value of MRI in detection of extracapsular extension in prostate cancer: A prospective study comparing imaging and histology - Abstract February 27, 2014

Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy - Abstract February 27, 2014

Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European Compassionate-Use Programme - Abstract February 27, 2014

Second primary cancers after radiation for prostate cancer: A systematic review of the clinical data and impact of treatment technique - Abstract February 27, 2014

Conventional margins not sufficient for post-prostatectomy prostate bed coverage: An analysis of 477 cone-beam computed tomography scans - Abstract February 27, 2014

Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and Gleason score as biopsy-based predictors of prostate cancer mortality: The Mayo Model - Abstract February 27, 2014

Evaluation of D'Amico criteria for low-risk prostate cancer - Abstract February 27, 2014

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial - Abstract February 27, 2014

Immunotherapy for prostate cancer: Recent developments and future challenges - Abstract February 26, 2014

Immigration factors and prostate cancer survival among Hispanic men in California: Does neighborhood matter? - Abstract February 26, 2014

Prostate-specific antigen bounce following stereotactic body radiation therapy for prostate cancer - Abstract February 26, 2014

Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection - Abstract February 26, 2014

Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence - Abstract February 26, 2014

Page 1058 of 1436